161 related articles for article (PubMed ID: 6500451)
21. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
[TBL] [Abstract][Full Text] [Related]
22. Isovolemic hemodilution: a therapeutical intervention for improving microcirculation.
Rudofsky G
Int Angiol; 1986; 5(3):151-4. PubMed ID: 3559316
[TBL] [Abstract][Full Text] [Related]
23. [Nonsurgical reconstructive treatment of peripheral arterial occlusive disease].
Altmann E; Schmidt PK; Hoffmann A; Spranger C; Förster HJ; Schwabe W
Z Arztl Fortbild (Jena); 1987; 81(17):871-7. PubMed ID: 2964128
[No Abstract] [Full Text] [Related]
24. [Significance of geriatric polypathy for conservative diagnosis and therapy of arterial occlusive disease in advanced age].
Nobbe F
Z Gerontol; 1985; 18(1):10-6. PubMed ID: 4002813
[TBL] [Abstract][Full Text] [Related]
25. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
26. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
27. [Current therapy of chronic arterial occlusive diseases of the lower extremities].
Thiele P; Runge E; Hempel G; Gatzweiler C; Geissler S; Schröder HE
Z Gesamte Inn Med; 1987 Dec; 42(23):661-7. PubMed ID: 3328437
[TBL] [Abstract][Full Text] [Related]
28. [The influence of hemorrheology on the practice of clinical medicine].
Dormandy JA
Ric Clin Lab; 1983; 13 Suppl 3():7-27. PubMed ID: 6369497
[TBL] [Abstract][Full Text] [Related]
29. [Conservative therapy of peripheral arterial occlusive diseases].
Alexander K
Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
[TBL] [Abstract][Full Text] [Related]
30. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of peripheral arterial occlusive disease].
Mahler F
Praxis (Bern 1994); 2001 Jan; 90(4):108-12. PubMed ID: 11213570
[TBL] [Abstract][Full Text] [Related]
32. Treatment modalities in peripheral vascular disease.
Doyle JE
Nurs Clin North Am; 1986 Jun; 21(2):241-53. PubMed ID: 2939399
[TBL] [Abstract][Full Text] [Related]
33. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
Schmid-Schönbein H
Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of peripheral occlusive disorders in diabetes mellitus].
Podhaisky H; Hänsgen K
Z Arztl Fortbild (Jena); 1987; 81(17):907-9. PubMed ID: 2964129
[No Abstract] [Full Text] [Related]
35. Isovolemic hemodilution as a functional therapy of decompensated arteriosclerotic stenoses of the femoral, cerebral and ophthalmic artery.
Schmid-Schönbein H; Rieger H
Ric Clin Lab; 1983; 13 Suppl 3():29-52. PubMed ID: 6673004
[TBL] [Abstract][Full Text] [Related]
36. [Can normovolemic hemodilution really modify blood flow in the limbs?].
Guerrini M; Pieragalli D; Acciavatti A; Cappelli R; Pecchi S; Forconi S; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():439-44. PubMed ID: 6673027
[TBL] [Abstract][Full Text] [Related]
37. [Ambulatory hemodilution therapy of peripheral arterial circulation disorders].
Wohlleben E; Wohlleben H; Voigt H; Köhler H
Z Gesamte Inn Med; 1981 Nov; 36(21):838-9. PubMed ID: 7331388
[TBL] [Abstract][Full Text] [Related]
38. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
Krupiński K; Bielawiec M; Szpak A; Płonowski A
Mater Med Pol; 1994; 26(1):17-20. PubMed ID: 7857406
[TBL] [Abstract][Full Text] [Related]
39. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
40. [The therapy of peripheral obstructive arteriopathies: rational bases].
Laghi Pasini F; Camarda M; Di Perri T
Recenti Prog Med; 1993; 84(7-8):534-40. PubMed ID: 8356309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
